CD34 and acute lymphoblastic leukemia: In a large cohort of 2028 children with ALL, the treatment outcomes of a subset of B-lineage ALL patients with CD10+CD19+CD34+ immature B-progenitor leukemia were compared with the treatment outcomes of the remaining CD19+ B-lineage ALL patients.